Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | WNT3A | P56704 | 6/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12840363 | 0.90 | KMT2A (0.46) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12840371 | 0.89 | TMIGD3 (0.43) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12840376 | 0.89 | KMT2A (0.46) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12840364 | 0.89 | KMT2A (0.45) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12839947 | 0.86 | RIOK2 (0.49) | KMT2AMEN1WNT3A | |
| SCHEMBL12838488 | 0.86 | DEGS1 (0.47) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL13068291 | 0.85 | TMIGD3 (0.43) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL13068038 | 0.85 | MAPK14 (0.46) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12840377 | 0.85 | CACNA1H (0.41) | TMIGD3KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12839097 | 0.84 | ROCK1 (0.44) | TMIGD3KMT2AMEN1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | JNC CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | CACYBP, CHLSN, LCP2 | TMIGD3 1782/4885KMT2A 4653/4885MEN1 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.